Skip to main content
Back to Deerfield

Deerfield's Therapeutics Portfolio

Browse 27 Therapeutics companies funded by Deerfield. See funding amounts, founder contacts, and investment details.

Therapeutics Companies
27
Total Funding in Therapeutics
$2.5B

Therapeutics Portfolio Companies (27)

Export
BiotechnologyLife ScienceTherapeutics

Vicinitas Therapeutics is a biotech startup that specializes in developing medicines that impact patient lives.

San Francisco, United States
July 2022
$65.0M
Series A

Founder Contacts

41,000+ verified contacts

BiotechnologyHealth CarePharmaceuticalTherapeutics

Adaptive Phage Therapeutics provides therapeutic services intended to treat multi-drug resistant pathogenic bacteria.

Bethesda, United States
June 2023
$12.0M
Series B

Founder Contacts

41,000+ verified contacts

BiopharmaBiotechnologyLife SciencePharmaceuticalPrecision MedicineTherapeutics

Frontier Medicines is a biopharmaceutical company that develops a chemoproteomics platform to accelerate the development of medicines.

San Francisco, United States
June 2024
$20.0M
Series C

Founder Contacts

41,000+ verified contacts

BiotechnologyHealth CareTherapeutics

Abivax develops medicines that alter the body's natural immune system mechanisms.

Paris, France
May 2026
$45.0M
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

BiotechnologyLife ScienceOncologyTherapeutics

Werewolf Therapeutics operates as an oncology biotherapeutics company.

Cambridge, United States
May 2022
$50.0M
Post-IPO Secondary

Founder Contacts

41,000+ verified contacts

BiotechnologyMedicalOncologyTherapeutics

Oncorus is an immuno-oncology company developing oncolytic viruses to fight cancer.

Cambridge, United States
April 2022
$20.0M
Post-IPO Debt

Founder Contacts

41,000+ verified contacts

BiotechnologyHealth CareTherapeutics

Ray Therapeutics is a biotech company that develops optogenetic gene therapies for patients with blinding diseases.

San Diego, United States
April 2026
$125.0M
Series B

Founder Contacts

41,000+ verified contacts

BiotechnologyClinical TrialsHealth CareTherapeutics

Neomorph develops protein degradation therapies targeting diseases not addressed by conventional treatments.

San Diego, United States
April 2026
$100.0M
Series B

Founder Contacts

41,000+ verified contacts

BiopharmaBiotechnologyLife ScienceOncologyTherapeutics

Bicara Therapeutics develops dual-action cancer therapies, combining targeted treatments with tumor modulators for enhanced impact.

Cambridge, United States
February 2026
$150.0M
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Life SciencePharmaceuticalTherapeutics

Perceive Pharma operates as a pharmaceutical company.

San Francisco, United States
February 2025
$15.0M
Series A

Founder Contacts

41,000+ verified contacts

BiopharmaTherapeutics

BBOT is a clinical-stage biopharmaceutical company advancing a pipeline of novel therapeutics targeting RAS and PI3K malignancies.

Palo Alto, United States
May 2024
$200.0M
Venture - Series Unknown

Founder Contacts

41,000+ verified contacts

BiopharmaBiotechnologyHealth CareLife ScienceTherapeutics

Foghorn Therapeutics is developing therapies based on a system that directs which genes our cells express,

Cambridge, United States
January 2026
$50.0M
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

BiopharmaBiotechnologyLife ScienceTherapeutics

Perceive Biotherapeutics is a biotechnology company pioneering novel technologies and therapeutics in ophthalmology.

South San Francisco, United States
January 2023
$78.0M
Series B

Founder Contacts

41,000+ verified contacts

BiotechnologyGeneticsMedicalTherapeutics

GBT is a clinical-stage biopharmaceutical company developing a therapy for sickle cell disease.

South San Francisco, United States
December 2021
$300.0M
Post-IPO Debt

Founder Contacts

41,000+ verified contacts

Health CareHospitalNeuroscienceTherapeutics

Cortica provides neurological therapies for children with autism and other developmental differences.

San Diego, United States
November 2024
$80.0M
Venture - Series Unknown

Founder Contacts

41,000+ verified contacts

BiotechnologyLife ScienceTherapeutics

Nuvalent is a biopharmaceutical company that develops targeted therapies for cancer by designing small-molecule medicines.

Cambridge, United States
November 2025
$500.0M
Post-IPO Secondary

Founder Contacts

41,000+ verified contacts

BiopharmaBiotechnologyMedicalTherapeutics

ADC Therapeutics develops antibody drug conjugates and non-antibody drug conjugate products.

Lausanne, Switzerland
October 2025
$60.0M
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

BiotechnologyHealth CareTherapeutics

BIOMx is a microbiome therapeutics company developing synbio phage therapies to eradicate harmful bacteria in chronic diseases.

Ness Ziona, Israel
December 2025
$3.0M
Post Ipo Equity

Founder Contacts

41,000+ verified contacts

BiotechnologyHealth CareMedicalTherapeutics

Valneva focuses on the development and commercialization of prophylactic vaccines for infectious diseases.

Saint-herblain, France
October 2025
$215.0M
Post Ipo Debt

Founder Contacts

41,000+ verified contacts

BiotechnologyConsultingManufacturingTherapeutics

Ascend Gene & Cell Therapies is a model for gene and cell therapy manufacturing.

Potters Bar, United Kingdom
May 2023
$65.9M
Series A

Founder Contacts

41,000+ verified contacts

BiotechnologyHealth CareTherapeutics

Chondrial Therapeutics is clinical-stage biotechnology that focuses on developing orphan drugs for mitochondrial diseases.

Bala Cynwyd, United States
May 2019
$25.8M
Series B

Founder Contacts

41,000+ verified contacts

BiotechnologyHealth CareTherapeutics

Stelexis Therapeutics is a company utilizes pre-cancerous stem cells to discover and develop transformative therapies.

New York, United States
January 2019
$43.0M
Series A

Founder Contacts

41,000+ verified contacts

BiopharmaHealth CarePharmaceuticalTherapeutics

Blade Therapeutics is a discovery stage drug development company.

South San Francisco, United States
November 2018
Series Unknown

Founder Contacts

41,000+ verified contacts

Therapeutics

Poseidon Innovation is a provider of advance disease curing therapeutics for risky early-stage processes.

San Diego, United States
September 2018
$65.0M
Series Unknown

Founder Contacts

41,000+ verified contacts

BiotechnologyTherapeutics

Lakeside Discovery accelerates the translation of transformative biomedical technologies.

New York, United States
June 2018
$65.0M
Series Unknown

Founder Contacts

41,000+ verified contacts

Product ResearchTherapeutics

Company that will support Vanderbilt’s innovative life science research .

New York, United States
March 2018
$65.0M
Series Unknown

Founder Contacts

41,000+ verified contacts

Health CarePharmaceuticalTherapeutics

New American Therapeutics is a specialty pharmaceutical company that acquires, markets and develops products in select therapeutic areas.

Parsippany, United States
September 2010
$53.0M
Series Unknown

Founder Contacts

41,000+ verified contacts

Explore Deerfield's Full Portfolio

View all companies funded by Deerfield across every industry and funding stage.

View Full Deerfield Portfolio